Lora Clawson

3.8k total citations · 2 hit papers
36 papers, 2.6k citations indexed

About

Lora Clawson is a scholar working on Neurology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lora Clawson has authored 36 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 13 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lora Clawson's work include Amyotrophic Lateral Sclerosis Research (23 papers), Neurogenetic and Muscular Disorders Research (13 papers) and Palliative Care and End-of-Life Issues (7 papers). Lora Clawson is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (23 papers), Neurogenetic and Muscular Disorders Research (13 papers) and Palliative Care and End-of-Life Issues (7 papers). Lora Clawson collaborates with scholars based in United States, Netherlands and United Kingdom. Lora Clawson's co-authors include Jeffrey D. Rothstein, Ralph W. Kuncl, Noah Lechtzin, Charles Wiener, Alan Pestronk, Daniel B. Drachman, Thomas O. Crawford, Margaret Dykes‐Hoberg, Lynn A. Bristol and Jin Li and has published in prestigious journals such as Neuron, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Lora Clawson

36 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis

1998 549 citations Chien-Liang Lin, Lynn A. Bristol et al. Neuron profile →
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1990 509 citations Jeffrey D. Rothstein, Guochuan Tsai et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lora Clawson United States	24	1.8k	901	689	592	309	36	2.6k
Vincenzo La Bella Italy	34	1.9k 1.1×	1.1k 1.3×	559 0.8×	934 1.6×	344 1.1×	112	3.3k
Pierre‐François Pradat France	30	2.6k 1.5×	1.5k 1.7×	425 0.6×	669 1.1×	364 1.2×	77	3.4k
Benjamin C. Cheah Australia	17	2.2k 1.2×	1.2k 1.3×	432 0.6×	581 1.0×	368 1.2×	28	3.0k
Jeffrey Rosenfeld United States	19	2.1k 1.2×	1.2k 1.3×	246 0.4×	260 0.4×	333 1.1×	32	2.5k
Errol Malta United States	9	2.2k 1.3×	1.1k 1.3×	345 0.5×	335 0.6×	435 1.4×	18	2.8k
Yasuo Iwasaki Japan	25	1.3k 0.7×	389 0.4×	490 0.7×	556 0.9×	234 0.8×	168	2.4k
Philippe Couratier France	28	2.0k 1.1×	914 1.0×	598 0.9×	635 1.1×	407 1.3×	80	2.6k
Philippe Couratier France	25	1.9k 1.1×	1.2k 1.3×	209 0.3×	403 0.7×	248 0.8×	59	2.4k
Cristina Moglia Italy	33	3.3k 1.9×	1.8k 1.9×	385 0.6×	636 1.1×	686 2.2×	124	3.8k
Richard W. Orrell United Kingdom	36	2.2k 1.3×	1.2k 1.3×	700 1.0×	1.7k 2.8×	688 2.2×	90	4.1k

Countries citing papers authored by Lora Clawson

Since Specialization

Citations

This map shows the geographic impact of Lora Clawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora Clawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora Clawson more than expected).

Fields of papers citing papers by Lora Clawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lora Clawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora Clawson. The network helps show where Lora Clawson may publish in the future.

Co-authorship network of co-authors of Lora Clawson

This figure shows the co-authorship network connecting the top 25 collaborators of Lora Clawson. A scholar is included among the top collaborators of Lora Clawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lora Clawson. Lora Clawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Angrick, Miguel, Shiyu Luo, Qinwan Rabbani, et al.. (2025). Real-time detection of spoken speech from unlabeled ECoG signals: a pilot study with an ALS participant. Journal of Neural Engineering. 22(5). 56023–56023. 1 indexed citations

Tehrani, Ali S. Saber, Shervin Badihian, Héctor Rieiro, et al.. (2024). Self-Recording of Eye Movements in Amyotrophic Lateral Sclerosis Patients Using a Smartphone Eye-Tracking App. SHILAP Revista de lepidopterología. 8(1). 111–119. 3 indexed citations

Luo, Shiyu, Miguel Angrick, Qinwan Rabbani, et al.. (2024). A click-based electrocorticographic brain-computer interface enables long-term high-performance switch scan spelling. SHILAP Revista de lepidopterología. 4(1). 207–207. 4 indexed citations

Angrick, Miguel, Shiyu Luo, Qinwan Rabbani, et al.. (2024). Online speech synthesis using a chronically implanted brain–computer interface in an individual with ALS. Scientific Reports. 14(1). 9617–9617. 29 indexed citations

Luo, Shiyu, Miguel Angrick, Christopher Coogan, et al.. (2023). Stable Decoding from a Speech BCI Enables Control for an Individual with ALS without Recalibration for 3 Months. Advanced Science. 10(35). e2304853–e2304853. 39 indexed citations

Felgoise, Stephanie H., Richard A. Feinberg, Helen Stephens, et al.. (2018). ALS Specific Quality of Life- Short Form (ALSSQOL-SF): A Brief, Reliable and Valid Version of the ALSSQOL-R. Muscle & Nerve. 2 indexed citations

Stommel, Elijah W., Kristen Riley, Rup Tandan, et al.. (2017). Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS). Journal of Neurology. 264(8). 1763–1767. 4 indexed citations

Clawson, Lora, Merit Cudkowicz, Lisa S. Krivickas, et al.. (2017). A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 19(3-4). 250–258. 47 indexed citations

Ching, Kathryn H., et al.. (2010). Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis. Neuromuscular Disorders. 21(3). 204–213. 16 indexed citations

10.

Pascuzzi, Robert M., Jeremy M. Shefner, Amy S. Chappell, et al.. (2009). A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 11(3). 266–271. 100 indexed citations

11.

Nolan, Marie T., Mark T. Hughes, Joan Kub, et al.. (2009). Development and validation of the Family Decision-Making Self-Efficacy Scale. Palliative & Supportive Care. 7(3). 315–321. 50 indexed citations

12.

Lechtzin, Noah, et al.. (2008). Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes. Amyotrophic Lateral Sclerosis. 10(4). 244–247. 6 indexed citations

13.

Lechtzin, Noah, et al.. (2007). Early use of non‐invasive ventilation prolongs survival in subjects with ALS. Amyotrophic Lateral Sclerosis. 8(3). 185–188. 115 indexed citations

14.

Schmidt, Eric P., Daniel B. Drachman, Charles Wiener, et al.. (2005). Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design. Muscle & Nerve. 33(1). 127–132. 62 indexed citations

15.

Lechtzin, Noah, Charles Wiener, Lora Clawson, et al.. (2004). Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 5(1). 9–15. 37 indexed citations

16.

Miller, Rupert G., et al.. (2001). The ALS Patient Care Database: Insights into End-of-Life Care in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2(4). 203–208. 55 indexed citations

17.

Lin, Chien-Liang, Lynn A. Bristol, Jin Li, et al.. (1998). Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis. Neuron. 20(3). 589–602. 549 indexed citations breakdown →

18.

Drachman, Daniel B., Vinay Chaudhry, David R. Cornblath, et al.. (1994). Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Annals of Neurology. 35(2). 142–150. 71 indexed citations

19.

Rothstein, Jeffrey D., Guochuan Tsai, Ralph W. Kuncl, et al.. (1990). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Annals of Neurology. 28(1). 18–25. 509 indexed citations breakdown →

20.

Pestronk, Alan, et al.. (1989). Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Annals of Neurology. 25(1). 98–102. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact